Question | Discussion | References | CME Credit

Case 3: References

  1. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000;342:1027-38.
    [The following link will open in a new window. PubMed Abstract]
  2. Centers for Disease Control. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR Recomm Rep. 1992;41 (RR-17):1-19. Available at:
    [The following link will open in a new window. Centers for Disease Control and Prevention - Accessed June 30, 2004]
  3. Chang Y, Cesarman E, Pessin M, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-9.
    [The following link will open in a new window. PubMed Abstract]
  4. Whitby D, Howard M, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995;346:799-802.
    [The following link will open in a new window. PubMed Abstract]
  5. Cesarman E, Chang Y, Moore P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Engl J Med. 1995;332:1186-91.
    [The following link will open in a new window. PubMed Abstract]
  6. Soulier J, Grollet L, Oskenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86:1276-80.
    [The following link will open in a new window. PubMed Abstract]
  7. Pauk J., Huang M.-L, Brodie SJ.,et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343:1369-77.
    [The following link will open in a new window. PubMed Abstract]
  8. Ensoli B, Barillari G, Gallo RC. Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematol Oncol Clin North Am. 1991;5:281-94.
    [The following link will open in a new window. PubMed Abstract]
  9. Ablin J, Ackerman Z, Eliakim R. Diffuse gastrointestinal hemorrhage as a presentation of systemic Kaposi sarcoma. Am J Gastroenterol. 1998;93:1390-1.
    [The following link will open in a new window. PubMed Abstract]
  10. Cattelan A, Calabro M, Gasperini P, et al. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J Natl Cancer Inst Monogr. 2001;28:44-9.
    [The following link will open in a new window. PubMed Abstract]
  11. Tirelli U, Bernardi D, Spina M, Vaccher E. AIDS-related tumors: integrating antiviral and anticancer therapy. Crit Rev Oncol Hematol. 2002;41:299-315.
    [The following link will open in a new window. PubMed Abstract]
  12. Pellet C, Chevret S, Blum L, et al. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol. 2001;117:858-63.
    [The following link will open in a new window. PubMed Abstract]
  13. Chak LY, Gill PS, Levine LM, et al. Radiation therapy for acquired immunodeficiency syndrome-related KS. J Clin Oncol. 1998;6:863-7.
    [The following link will open in a new window. PubMed Abstract]
  14. Tappero JW, Conant MA, Wolfe SF, et al., Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria, and therapy. J Am Acad Dermatol. 1993;28:371-95.
    [The following link will open in a new window. PubMed Abstract]
  15. Boudreaux A, Smith L, Cosby C, et al. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficacy and discomfort associated with injection. J Am Acad Dermatol. 1993;28:61-5.
    [The following link will open in a new window. PubMed Abstract]
  16. Walmsley S, Northfelt DW, Meloskey B, et al. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin gel. Panretin Gel North American Study Group. J Acquir Immune Defic Syndr. 1999;22:235-46.
    [The following link will open in a new window. PubMed Abstract]
  17. Cooper J, Steinfeld A, Lerch I. Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1990;20:419-22.
    [The following link will open in a new window. PubMed Abstract]
  18. de Wit R, Smit W, Veenhof K, et al. Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy. Radiother Oncol. 1990;19:131-6.
    [The following link will open in a new window. PubMed Abstract]
  19. Gill PS, Rarick M, McCutchan JA, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial. Am J Med. 1991;90:427-33.
    [The following link will open in a new window. PubMed Abstract]
  20. Gill PS, Tulpule A, Espina BM, et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999;17:1876-83.
    [The following link will open in a new window. PubMed Abstract]
  21. Cianfrocca M, Cooley TP, Lee JY, et al. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol. 2002;20:153-9.
    [The following link will open in a new window. PubMed Abstract]
  22. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med. 1999;340:1063-70.
    [The following link will open in a new window. PubMed Abstract]

[Back to Case 3 Question | Back to Discussion]

CME Credit | Back to Top